MilliporeSigma invests US$ 76 million to expand ADC manufacturing in North America
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency
The workshop aimed to equip medicos with the necessary skills & knowledge to leverage AI's transformative power
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
Spread over 1.26 lakh sq ft building, the super-specialty eye hospital will perform 30,000 free eye surgeries annually for economically weaker sections
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
The net-zero target approval complements the company's near-term emission reduction targets
Subscribe To Our Newsletter & Stay Updated